| [1] |
Bray F, Ferlay J, Soerjtaram I，et al.Global cancer statistics 2018：Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]．Cancer Clin，2018: 21492.
|
| [2] |
Malfertheiner P, Megraud F, O'Morain CA，et al.Management of Helicobacter pyloriinfection-the Maastricht V/Florence Consensus Report[J]．Gut，2017，66(1): 6-30.
|
| [3] |
Yoon H, Kim N, Lee HS，et al.Helicobacter pylori-negative gastric cancer in South Korea：incidence and clinicopathologic characteristics [J]．Helicobacter，2011，16(5): 382-388.
|
| [4] |
Sergio AC, Hiroaki T, Gil RC-C，et al.Role of bacterial and genetic factors in gastric cancer in Costa Rica[J]．World J Gastroenterol，2009，15(2): 211-218.
|
| [5] |
Roman-Roman A, Martinez Carrillo DN, Atrisco-Morales J，et al.Helicobacter pylori VacA s1m1 genotype but not CagA or BabA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico[J]．Gut Pathog，2017，9(1): 18-29.
|
| [6] |
Matos JI, Marcos-Pinto R, Dinis-Ribeiro M．Helicobacter pylori CagA and VacA genotypes and gastric phenotype：a meta-analysis[J]．Gastroenterol Hepatol，2013，25(12): 1431-1441.
|
| [7] |
Li Q, Liu J, Gong Y, Yuan Y. Association of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks：a meta analysis[J]．Medicine (Baltimore)，2017，96(17): e6620.
|
| [8] |
Sinnett CG, Letley DP, Narayanan GL，et al. Helicobacter pylori vacA transcription is genetically-determined and stratifies the level of human gastric inflammation and atrophy[J]．Clin Pathol，2016，69(11): 968-973.
|
| [9] |
Aasen T, Mesnil M, Naus CC，et al.Gap junctions and cancer：Communicating for 50 years[J]．Nat Rev Cancer，2016，16(12): 775-788.
|
| [10] |
Ogiwara H, Graham DY, Yamaoka Y．VacAi-region subtyping[J]. Gastroenterology，2008，134(4): 1267-1276.
|
| [11] |
Gonzalez CA, Figueiredo C, Ferreira RM，et al.Helicobacter pylori cagA and VacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain[J]．Gastroenterology，2011，106(5): 867-874.
|
| [12] |
曹世堂，易小兵，王玉华，等．幽门螺旋杆菌感染与胃癌组织中p27、CyclinD1、MIF蛋白表达的相关性分析[J]．实用医院临床杂志，2017，14(5): 154-157.
|
| [13] |
Vogelmann R, Covacci A, Falkow S，et al.Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA[J]．Science，2003，300: 1430-1434.
|
| [14] |
Wang F, Xia P, Wu F，et al.Helicobacter pylori VacA disrupts apical membrane-cytoskeletal interactions in gastric parietal cells[J]．Biol Chem，2008，283: 26714-26725.
|
| [15] |
Lina TT, Alzahrani S, Gonzalez J，et al.Immune evasion strategies used by Helicobacter pylori[J]．World J Gastroenterol，2014，20(36): 12753-12766.
|
| [16] |
Skibinski DA, Genisset C, Barone S, Telford JL.The cell-specifific phenotype of the polymorphic vacA midregion is independent of the appearance of the cell surface receptor protein tyrosine phosphatase beta[J]．Infect Immun，2006，74(1): 49-55.
|
| [17] |
Gonzalez-Rivera C, Algood HM, Radin JN，et al.The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay[J]．Infect Immun，2012，80(8): 2578-2588.
|
| [18] |
Tegtmeyer N, Neddermann M, Asche CI，et al.Subversion of host kinases：A key network in cellular signaling hijacked by Helicobacter pylori CagA[J]．Mol Microbiol，2017，105(3): 358-372.
|
| [19] |
雍鑫．CagA阳性幽门螺杆菌在促胃癌细胞干性特征增强中的作用及其机制研究[D]．第三军医大学，2016.
|
| [20] |
Buti L, Spooner E, Rappuoli R，et al.Helicobacter pylori cytotoxin-associated gene A(CagA)subverts the apoptosis stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host[J]．Proc Natl Acad Sci，2011，108(22): 9238-9243.
|
| [21] |
Kaplan-Turkoz B, Dian C, Ertl C，et al.Structural insights into Helicobacter pylori oncoprotein CagA interaction with beta1 integrin[J]．Proc Natl Acad Sci，2012，109(36): 14640-14645.
|
| [22] |
Akada J, Kitagawa T, Kurazono H，et al.Helicobacter pylori CagA inhibits endocytosis of cytotoxin VacA in host cells[J]．Dis Models Mech，2010，3(9-10): 605-617.
|
| [23] |
Park YH, Kim N．Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer[J]．Cancer Prev，2015，20(1): 25-40.
|
| [24] |
Hwang YJ, Kim N, Lee HS，et al.Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication-a prospective study for up to 10 years[J]．Aliment Pharmacol Ther，2017，47(3): 380-390.
|
| [25] |
Sonnenberg A. Review article: historic changes of Helicobacter pylori associated diseases[J]．Aliment Pharmacol Ther，2013，38(4): 329-342.
|
| [26] |
Kim N, Park YS, Cho SI， et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease[J]．Helicobacter，2008，13(4): 245-55.
|
| [27] |
Houghton J, Stoicov C, Nomura S，et al.Gastric cancer originating from bone marrowderived cells[J]．Science，2004，306(5701): 1568-1571.
|
| [28] |
Kim YI, Choi IJ, Kook MC，et al.The association between Helicobacter pylori status and incidence of metachronous gastric cancer after endoscopic resection of early gastric cancer[J]．Helicobacter，2014，19(3): 194-201.
|
| [29] |
Wong BC, Lam SK, Wong WM，et al.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China：a randomized controlled trial[J]．JAMA，2004，291(2): 187-194.
|
| [30] |
Shichijo S, Hirata Y, Niikura R，et al.Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication[J]．Gastrointest Endosc，2016，84(4): 618-624.
|
| [31] |
Lee YC, Chiang TH, Chou CK，et al.Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence：A Systematic Review and Meta-analysis[J]．Gastroenterology，2016，150(5): 1113-1124.
|
| [32] |
Tsuda M, Asaka M, Kato M，et al.Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan[J]．Helicobacter，2017，22(5): e12415.
|
| [33] |
Mera RM, Bravo LE, Camargo MC，et al.Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions：16-year follow-up of an eradication trial[J]．Gut，2018，67(7): 1239-1246.
|
| [34] |
Bae SE, Choi KD, Choe J，et al.The effect of eradication of Helicobacter pylori on gastric cancer prevention in healthy asymptomatic populations[J]. Helicobacter，2018，e12464.
|
| [35] |
Bae SE, Jung HY, Kang J，et al.Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm[J]．Gastroenterol，2014，109(1): 60-67.
|
| [36] |
Kiriyama Y, Tahara T, Shibata T，et al. Gastric-and-intestinal mixed intestinal metaplasia is irreversible point with eradication of Helicobacter pylori[J]. Pathology，2016，6(2): 93-104.
|
| [37] |
Oh S, Kim N, Kwon JW，et al.Effect of Helicobacter pylori eradication and ABO genotype on gastric cancer development[J]．Helicobacter，2016，21(6): 596-605.
|
| [38] |
Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori：a combined analysis of 12 case control studies nested within prospective cohorts[J]．Gut，2001，49(3): 347-53.
|
| [39] |
Chiba T, Marusawa H, Ushijima T．Inflammation-associated cancer development in digestive organs：mechanisms and roles for genetic and epigenetic modulation[J]．Gastroenterology，2012，143(3): 550-563.
|
| [40] |
Shin CM, Kim N, Lee HS，et al.Changes in aberrant DNA methylation after Helicobacter pylori eradication：a long-term follow-up study[J]．Int J Cancer，2013，133(9): 2034-2042.
|